Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy - Wikidata - awgldk - TriplyDB

Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy

Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy

http://www.wikidata.org/entity/Q34340994

about

Imagined gait modulates neuronal network dynamics in the human pedunculopontine nucleus Brainstem control of locomotion and muscle tone with special reference to the role of the mesopontine tegmentum and medullary reticulospinal systems Ageing and Parkinson's disease: why is advancing age the biggest risk factor?Parkinson's disease as a result of aging Anatomy, physiology, and pathophysiology of the pedunculopontine nucleus Functional circuitry involved in the regulation of whisker movements Pedunculopontine nucleus deep brain stimulation in Parkinson's disease.Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease Turning heads: development of vertebrate branchiomotor neurons.Involvement of cholinergic system in hyperactivity in dopamine-deficient mice.Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson's disease Physiology of freezing of gait.Nigropedunculopontine projection in the rat: an anterograde tracing study with phaseolus vulgaris-leucoagglutinin (PHA-L).Cerebrospinal fluid acetylcholinesterase in progressive supranuclear palsy: reduced activity relative to normal subjects and lack of inhibition by oral physostigmine The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease.Dopamine and the Brainstem Locomotor Networks: From Lamprey to Human Sleep disorders in Parkinsonian macaques: effects of L-dopa treatment and pedunculopontine nucleus lesion.Rapid Alleviation of Parkinson's Disease Symptoms via Electrostimulation of Intrinsic Auricular Muscle Zones.Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected.Flow cytometry analysis of synaptosomes from post-mortem human brain reveals changes specific to Lewy body and Alzheimer's disease.Mitochondrial abnormality associates with type-specific neuronal loss and cell morphology changes in the pedunculopontine nucleus in Parkinson disease The effects of deep brain stimulation on sleep in Parkinson's disease.Brainstem motor loops in the control of movement.Altered neuronal activity relationships between the pedunculopontine nucleus and motor cortex in a rodent model of Parkinson's disease.An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease.Highlighting the Versatility of the Tracerlab Synthesis Modules. Part 1: Fully Automated Production of [F]Labelled Radiopharmaceuticals using a Tracerlab FX(FN).Using motor imagery to study the neural substrates of dynamic balance.Colocalization of nitric oxide synthase and somatostatin immunoreactivity in rat dentate hilar neurons.Modeling Parkinson's disease falls associated with brainstem cholinergic systems decline.Alpha oscillations in the pedunculopontine nucleus correlate with gait performance in parkinsonism Psychotic symptoms in Parkinson's disease: pathophysiology and management.Sleep disturbances in Alzheimer's and Parkinson's diseases.Parkinson's disease with camptocormia.Vestibular responses in the macaque pedunculopontine nucleus and central mesencephalic reticular formation.The cholinergic mesopontine tegmentum is a relatively neglected nicotinic master modulator of the dopaminergic system: relevance to drugs of abuse and pathology.Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality?Persons with Parkinson's disease exhibit decreased neuromuscular complexity during gait.Maintaining balance against force perturbations: impaired mechanisms unresponsive to levodopa in Parkinson's disease.Neuronal loss in the caudal intralaminar thalamic nuclei in a primate model of Parkinson's disease.

P2860

Q21147053-AC2F486D-37B8-43D7-AD50-6B58C82EB16F Q26779826-445D2E9C-1627-4412-91A9-8417BAAC1220 Q27021628-44CE4A65-B65E-4B24-A5B3-678B52D4016D Q28084395-65EAD916-775D-4DBC-BCEA-153FEBC2C5B4 Q28304606-A120844A-DAA9-4E11-B5A8-012A084E76BA Q28344480-5CC7AD7D-66A5-4833-854D-A13259606A36 Q30471148-1917C967-6FE9-4D6A-9DE9-D1B19563D8FE Q30495761-809F2CD8-9BF8-49C2-9BF8-5249DA723061 Q30497143-7F67C2FA-3C83-4224-B1B2-0A7D169711A8 Q30630420-8D373702-F153-4F78-B1D3-307D9F08C8EE Q30665304-E2F4D041-F169-4FE8-99EC-93645216EDA4 Q31131953-0EFDAAA7-7A04-4C48-B0FE-BC21791F826F Q33268071-A3622064-DF15-4F77-81C8-42CB739BCA65 Q33589820-E4744B40-E71F-453E-8F22-83F015EF5CB1 Q33630854-8A1D1DC5-3F20-4757-B1CA-CD691E910F72 Q33729550-DF0DFA3B-7875-4953-9CD6-A8C059E51D2A Q33832153-BC865457-4E47-46C9-B558-A71E2F023155 Q33843309-BB3E3CDA-FC49-40AF-8691-2BF9B5A6F91D Q34135495-A0CF47C7-3D69-4016-AA3C-40B53279B58D Q34239492-5ACBA485-03E0-47D9-BAA8-F548585B347C Q34287848-D7FC5B06-0055-4318-98D2-07551B75C4C7 Q34299923-BA0080A4-C092-4BAD-83DE-EBCA6DA9FCFE Q34565674-DC32B7DB-930C-4061-BCC4-92A002A5EBD4 Q34596334-6750476E-3923-4C90-A0F3-EF2ADA8E9671 Q35053904-5AD25F06-DD45-495A-9CFB-9A6B94A9B977 Q35057159-592E5E12-6F68-4484-8274-CB615744733B Q35108246-18D090AB-AA2E-4B75-8EC5-E487C70BE846 Q35129366-E9E94964-C878-4A71-A522-AB4E03D1718F Q35146355-A0ED1F73-F0CB-4E70-B152-E914E309EB03 Q35360176-EAE7E71E-379C-47BC-83DE-8F11FB1CFAEE Q35706455-67FBAB70-91CD-49AB-BE7F-1178CEA00CB4 Q35779329-038FAB4E-3433-414B-9ADB-3849C6A8248A Q35981780-3F817E06-D90E-4DFB-89E6-3A72C7AFAF92 Q36141882-61F52E2B-101C-4B9F-A73A-3348C76062EE Q36358577-75A24A24-D7E9-4E28-B0AB-3F973969FEC0 Q36497025-A9C53562-4EE7-42E2-AC76-90F9C38103E8 Q36775249-11C90F96-B7CC-4F1A-A99E-EEB1B4D4397F Q36920073-648E6C93-61E9-4E38-BCEB-139E5CAAFE02 Q37162689-459976AD-A716-4373-BB45-A78B482FD58A Q37395632-CCD9BA88-2542-4403-9E92-BF70473661AB

P2860

Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy

http://www.wikidata.org/entity/Q34340994

description

1987 nî lūn-bûn

@nan

1987 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1987 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1987年の論文

@ja

1987年論文

@yue

1987年論文

@zh-hant

1987年論文

@zh-hk

1987年論文

@zh-mo

1987年論文

@zh-tw

1987年论文

@wuu

name

Neuronal loss in the pedunculo ...... progressive supranuclear palsy

@ast

Neuronal loss in the pedunculo ...... progressive supranuclear palsy

@en

Neuronal loss in the pedunculo ...... progressive supranuclear palsy

@nl

type

label

Neuronal loss in the pedunculo ...... progressive supranuclear palsy

@ast

Neuronal loss in the pedunculo ...... progressive supranuclear palsy

@en

Neuronal loss in the pedunculo ...... progressive supranuclear palsy

@nl

prefLabel

Neuronal loss in the pedunculo ...... progressive supranuclear palsy

@ast

Neuronal loss in the pedunculo ...... progressive supranuclear palsy

@en

Neuronal loss in the pedunculo ...... progressive supranuclear palsy

@nl

P1433

Q34340994-88A278ED-0984-429A-9E26-1A08E822C690

P1476

Q34340994-4D189A30-8F77-4448-A992-9FBBB3747A3A

P2093

Q34340994-2661AD27-B80C-43E0-B5B4-8AEF3EAE8EAC

Q34340994-81AEA2F9-8DA1-494D-B567-4FEBDF6F6FFC

Q34340994-90D75DA6-3752-4C37-BE5B-D51DA94D2D48

Q34340994-AA02466A-E2FE-49AC-A45C-9C5800626E8B

P2860

Q34340994-0ACAFC97-A0A3-4566-8E70-FE0D71ABD620

Q34340994-1188379E-B0DC-409D-B209-8801F4FB7585

Q34340994-1D080863-4CD0-477F-B3B6-B213E01AE4ED

Q34340994-1D99EC80-C26F-43DD-994F-FACB93E3E002

Q34340994-3E2551A7-4036-4E70-A76B-22A0851C493E

Q34340994-3EB7293D-0AAA-43F7-8D3C-4FAB7A8313C2

Q34340994-443B4D57-6842-4F95-A923-C7435D7AE0D5

Q34340994-471776D2-DC9F-42D1-83EB-5D5D8BA1F137

Q34340994-4F4C6691-4DF0-4AE7-B414-B9BB7B5B4087

Q34340994-55E65739-E8C5-4FEA-8D7E-779AD69665C8

P304

Q34340994-C7A5AA15-B631-4C76-B8AD-ACD22D0AA5CA

P31

Q34340994-F81A42D7-8D5B-4CA4-B1E6-68EFA00ACCF9

P356

Q34340994-0AA7D50A-9F84-458A-8BBC-1E4E15F68D0F

P407

Q34340994-8E195516-36EE-459A-94E6-7A29B71F279C

P433

Q34340994-D99C2092-C317-441D-A16E-466C792E0E46

P478

Q34340994-AE68ADD0-035D-4F90-8970-5DCB7A02DD63

P577

Q34340994-FECF9281-35D6-433D-B3E0-5F4A13239769

P5875

Q34340994-23EC5858-795B-419F-BB00-5E69D6D2A94B

P698

Q34340994-05F8FF50-19CF-408A-B086-F7ADD155D5C9

P921

Q34340994-AA141B61-3342-4351-A717-87D758F006C7

P932

Q34340994-AB60A6C1-239A-4156-BB3E-203042624731

P356

PNAS.84.16.5976

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Neuronal loss in the pedunculo ...... progressive supranuclear palsy

@en

P2093

A M Graybiel

http://www.w3.org/2001/XMLSchema#string

C Duyckaerts

http://www.w3.org/2001/XMLSchema#string

E C Hirsch

http://www.w3.org/2001/XMLSchema#string

F Javoy-Agid

http://www.w3.org/2001/XMLSchema#string

P2860

Cholinergic systems in the rat brain: III. Projections from the pontomesencephalic tegmentum to the thalamus, tectum, basal ganglia, and basal forebrain

Projections of the lentiform nucleus in the monkey.

The ascending cholinergic reticular system: neocortical, olfactory and subcortical projections.

Differences in tyrosine hydroxylase-like immunoreactivity characterize the mesostriatal innervation of striosomes and extrastriosomal matrix at maturity.

The basal ganglia-circa 1982. A review and commentary.

Dopaminergic and cholinergic lesions in progressive supranuclear palsy.

Distribution of central cholinergic neurons in the baboon (Papio papio). I. General morphology.

Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6).

Basal forebrain neurons in the dementia of Parkinson disease.

Basal ganglia and other afferent projections to the peribrachial region in the rat: a study using retrograde and anterograde transport of horseradish peroxidase.

P304

5976-5980

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.84.16.5976

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P577

1987-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

19680057

http://www.w3.org/2001/XMLSchema#string

P698

3475716

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

298986

http://www.w3.org/2001/XMLSchema#string